NCT03916861

Brief Summary

This study was designed to compare the efficacy of BIA and physician adjustment to prevent intradialytic hypotension in patients with acute kidney injury who received renal replacement therapy. The investigators randomized 9 patients with acute kidney injury and volume overloaded who underwent acute hemodialysis for 45 sessions in Vajira hospital between October 2017 and February 2018. In physician adjust-group (control) estimate by physical examination and fluid balance record. Primary outcome was intradialytic hypotensive episode and secondary outcome was hemodialysis-related adverse events and other clinical outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 1, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
Last Updated

April 16, 2019

Status Verified

April 1, 2019

Enrollment Period

5 months

First QC Date

April 1, 2019

Last Update Submit

April 15, 2019

Conditions

Keywords

HemodialysisBIAAcute Kidney Injury

Outcome Measures

Primary Outcomes (1)

  • Change in blood pressure during dialysis

    Blood pressure less than 20 mmHg from baseline ( systolic blood pressure)

    During hemodialysis session start from enrollment until study completion, up to 4 hours

Secondary Outcomes (3)

  • Cardiac problem

    Measure through study completion,for at least 3 months after randomization

  • Hospital length of stay

    Up to 3 months after enrollment

  • Percent of renal function

    at least 3 months after enrollment

Study Arms (2)

Bioelectrical Impedance

EXPERIMENTAL

The first group will be monitored by Inbody S20 analysis to measure fluid status. The Bioimpedance will be measured each time prior to hemodialysis session . The value of BIA measurement of more than 0.4 will be considered as edema.

Device: Bioelectrical Impedance Analysis

Physicain-guided group

ACTIVE COMPARATOR

The fluid monitoring will be managed by physician-adjustment by physical examination and fluid balance record . The fluid balance (FB) is the total fluid administered minus the total fluids eliminated over a period of time.

Procedure: Physician-guided

Interventions

We use Inbody S20 analysis to measure fluid status before each hemodialysis session to guide fluid removal.

Bioelectrical Impedance

This intervention used physical examination as guided to adjust fluid therapy together with the chart record of intake and output per day

Also known as: Fluid balance record
Physicain-guided group

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsMore than 18 years old
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with acute kidney injury with volume overload unresponsive to medication therapy =Required renal replacement therapy (RRT)

You may not qualify if:

  • Patients who were pregnant
  • Advanced malignancy
  • Kidney transplantation
  • AKI from toxins
  • Currently on pacemaker
  • Had underlying chronic kidney disease
  • Patients with severe cardiovascular disease such as congestive heart failure, valvular regurgition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thananda Trakarnvanich

Bangkok, Bangkok, 10170, Thailand

Location

MeSH Terms

Conditions

Cardiovascular DiseasesRenal InsufficiencyAcute Kidney Injury

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Thananda Trakarnvanich

    Vajira Hospital ,Navamindradhiraj University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Prospective randomized study
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 1, 2019

First Posted

April 16, 2019

Study Start

October 1, 2017

Primary Completion

February 28, 2018

Study Completion

February 28, 2018

Last Updated

April 16, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations